MedPath

A comparative study to assess the effect of intense pulsed light therapy with topical 2.5% benzoyl peroxide versus topical 2.5% benzoyl peroxide alone in acne patients

Not Applicable
Conditions
Health Condition 1: L700- Acne vulgaris
Registration Number
CTRI/2022/07/044041
Lead Sponsor
R Aishwarya Meenaloshini
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

�Patients of both genders above 18 years & below 30 years with acne vulgaris.

�Not receiving any systemic or topical acne treatment for last 2 weeks.

�No tendency to develop keloid or hypertrophic scar.

�Not receiving topical and systemic steroids for last 6 months.

�Patients willing to give a written informed consent

Exclusion Criteria

Before starting the study

�Pregnant and lactating women.

�Women planning for pregnancy

�Patients with co-morbidities-DM,SHT,TB,CAD,EPILEPSY,BA,HIV

During Study

�If patient develops severe side effects during the treatment

�If patient wants alternate treatment during the study.

�If patient wants to discontinue the treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The end point will be the evaluation of clinical response to both the mode of treatment at 16 weeks after treatment initiation. Responses in between the study will be noticed & recorded using Comprehensive Acne Severity Scale(CASS) and patient satisfaction scoreTimepoint: 16 weeks
Secondary Outcome Measures
NameTimeMethod
To look for reduction of post acne pigmentation following treatment and recurrenceTimepoint: 8 weeks
© Copyright 2025. All Rights Reserved by MedPath